Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

Abstract Background While the number of therapeutic options for treating inflammatory bowel diseases (IBD) is increasing, evidence for rational treatment decisions is scarce in many cases. In particular, appropriate biomarkers to predict the response to the anti-α4β7 integrin antibody vedolizumab ar...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Entcho Klenske, Lisa Müller, Nadine Morgenstern, Konstantin Fietkau, Simon Hirschmann, Raja Atreya, Imke Atreya, Markus F. Neurath, Sebastian Zundler
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2020-04-01
Saila:BMC Gastroenterology
Gaiak:
Inflammatory bowel diseases
T cells
Vedolizumab
Adhesion
Gut homing
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s12876-020-01253-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak